Feasibility and Efficacy of Single-Port Robotic Cholecystectomy Using the da Vinci SP® Platform

Kim, Wan-Joon; Choi, Se Yeon; Kim, Wan-Bae

doi:10.4293/jsls.2021.00091

Cited by 5 publications

(8 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several series included the same population reducing the total number to 2819 patients (Table 1). Among the included studies, 36 were case reports , 52 were noncomparative studies , and 15 were comparative studies [99][100][101][102][103][104][105][106][107][108][109][110][111][112][113]. Only one study was a randomized controlled trial [103].…”

Section: Resultsmentioning

confidence: 99%

“…The reported cases belonged to several specialties: hepatopancreatobiliary surgery [13,[37][38][39][50][51][52][53][54][55]78,79,[87][88][89][90][91][92][93][94][95][96][97][100][101][102][103] (Tables S1 and S2), colorectal surgery [14-36,56- The authors belonged to institutions located in: South Korea (n = 27), China (n = 16), North America (n = 13), Lithuania (n = 11), Japan (n = 8), Germany (n = 6), Italy (n = 6), United Kingdom (n = 6), India (n = 4), United Arab Emirates (n = 2), Taiwan (n = 1), France (n = 1), Croatia (n = 1), Australia (n = 1).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

et al. 2023

View full text Add to dashboard Cite

Background and Objectives: Robotic surgery has been widely adopted in general surgery worldwide but access to this technology is still limited to a few hospitals. With the recent introduction of new robotic platforms, several studies reported the feasibility of different surgical procedures. The aim of this systematic review is to highlight the current clinical practice with the new robotic platforms in general surgery. Materials and Methods: A grey literature search was performed on the Internet to identify the available robotic systems. A PRISMA compliant systematic review was conducted for all English articles up to 10 February 2023 searching the following databases: MEDLINE, EMBASE, and Cochrane Library. Clinical outcomes, training process, operating surgeon background, cost-analysis, and specific registries were evaluated. Results: A total of 103 studies were included for qualitative synthesis after the full-text screening. Of the fifteen robotic platforms identified, only seven were adopted in a clinical environment. Out of 4053 patients, 2819 were operated on with a new robotic device. Hepatopancreatobiliary surgery specialty performed the majority of procedures, and the most performed procedure was cholecystectomy. Globally, 109 emergency surgeries were reported. Concerning the training process, only 45 papers reported the background of the operating surgeon, and only 28 papers described the training process on the surgical platform. Only one cost-analysis compared a new robot to the existing reference. Two manufacturers promoted a specific registry to collect clinical outcomes. Conclusions: This systematic review highlights the feasibility of most surgical procedures in general surgery using the new robotic platforms. Adoption of these new devices in general surgery is constantly growing with the extension of regulatory approvals. Standardization of the training process and the assessment of skills’ transferability is still lacking. Further studies are required to better understand the real clinical and economical benefit.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Then, SP robotic surgical systems are developed to further compensate for these limitations, among which the da Vinci SP surgical system is the most widely adopted platform and it has been reported in urology, gynaecology and general surgery. 6,[13][14][15][16][17]28,29 However, this new platform…”

Section: Discussionmentioning

confidence: 99%

“…Besides, since the robotic surgical system is usually composed of a 12‐mm endoscope and 8‐mm instruments, the umbilical incision in robotic LESS is larger than that in conventional single‐site approach, 27 which may have an increased risk of incisional complication. Then, SP robotic surgical systems are developed to further compensate for these limitations, among which the da Vinci SP surgical system is the most widely adopted platform and it has been reported in urology, gynaecology and general surgery 6,13–17,28,29 . However, this new platform has not yet been introduced to the mainland of China, and considering the high cost of the da Vinci Si/Xi system, it is assumed to partially offset its advantage since such advanced techniques have not been covered by the basic medical insurance that would be a great financial burden for most patients.…”

Section: Discussionmentioning

confidence: 99%

“…The Da Vinci SP surgical system designed by Intuitive Surgical is the first SP robotic system to come into clinical practice, which allows the surgery to be performed through a single cannula that houses three instruments and one camera on independent drivers 12 . Studies have reported the application of the da Vinci SP surgical system in urology, gynaecology and general surgery 6,13–16 . The instruments of the SP robotic system incorporate an additional joint, which helps reduce clashes of the instruments that may occur in traditional single‐site surgery and collision of arms in single‐site surgery with multi‐arms robotic system 17 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Single‐port robotic surgery using the EDGE SP1000 surgical system in gynaecology: Initial experience of a single institution

Chen,

Zheng,

Wang

et al. 2023

Robotics Computer Surgery

View full text Add to dashboard Cite

BackgroundThe EDGE SP1000 is a newly developed single‐port (SP) robotic surgical system whose clinical evaluation in gynaecology has not yet been addressed.MethodsThis is a single‐arm clinical trial evaluating the perioperative outcomes of patients receiving EDGE SP1000 assisted surgeries. Patients with either benign or malignant gynaecological diseases suitable for robotic surgery were included, and their data were prospectively collected.ResultsEighteen patients were included and 8 of them had malignant conditions. The total operative time was 190.1 ± 83.3 min for benign diseases and 254.4 ± 59.4 min for malignant diseases. The mean estimated blood loss was 25 mL (range, 5–100). No assistant ports or conversions were required. No perioperative complications occurred. Overall satisfaction with the umbilical wounds was expressed at the 1‐month follow‐up.ConclusionEDGE SP1000 SP robotic surgical system is technically feasible and safe in various gynaecological surgeries with good cosmetic effects.

show abstract

Da Vinci single-port robotic system current application and future perspective in general surgery: A scoping review

Celotto,

Ramacciotti,

Mangano

et al. 2024

Surg Endosc

View full text Add to dashboard Cite

Background The da Vinci Single-Port Robot System (DVSP) allows three robotic instruments and an articulated scope to be inserted through a single small incision. It received FDA approval in 2014 and was first introduced in 2018. The aim of this new system was to overcome the limitations of single-incision laparoscopic and robotic surgery. Since then, it has been approved for use only for urologic and transoral surgeries in some countries. It has been used as part of experimental protocols in general surgery. Objective By obtaining the CE mark at the end of January 2024, DVSP will soon enter the European market. This review aims to comprehensively describe the applications of DVSP in general surgery. Design A search of PubMed, Embase, and Ebsco databases up to March 2024 was conducted, with registration in PROSPERO (CRD42024536430), following the preferred reporting items for Systematic reviews and Meta-analyses for scoping review (PRISMA-Scr) guidelines. All the studies about the use of DVSP in general surgery were included. Results Fifty-six studies were included. The following surgical areas of use were identified: transabdominal and transanal colorectal, cholecystectomy, abdominal wall repair, upper gastroesophageal tract, liver, pancreas, breast, and thyroid surgery. The reported surgical and short-term outcomes are promising; a wide range of procedures have been performed safely. Some groups have found advantages, such as faster discharge, shorter operative time, and less postoperative pain compared to multiport robotic surgery. Conclusion Five years after its initial clinical applications, the use of the DVSP in general surgery procedures has demonstrated feasibility and safety. Hernia repair, cholecystectomy, and colorectal surgery emerge as the most frequently conducted interventions with this robotic system. Nevertheless, there is anticipation for further studies with larger sample sizes and extended follow-up periods to provide more comprehensive insights and data on the long-term outcomes, including the incidence of incisional hernia. Graphical Abstract

show abstract

Feasibility and Efficacy of Single-Port Robotic Cholecystectomy Using the da Vinci SP® Platform

Cited by 5 publications

References 23 publications

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

Single‐port robotic surgery using the EDGE SP1000 surgical system in gynaecology: Initial experience of a single institution

Da Vinci single-port robotic system current application and future perspective in general surgery: A scoping review

Contact Info

Product

Resources

About